- Nachrichtendetail
-
02.04.2024 08:04:50 - dpa-AFX: *ASTRAZENECA AND DAIICHI SANKYO: FDA ACCEPTS DATOPOTAMAB DERUXTECAN BLA FOR BREAST CANCER
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
DAIICHI SANKYO CO. LTD | A0F57T | Frankfurt | 34,460 | 07.08.24 08:20:44 | +1,020 | +3,05% | 34,600 | 35,320 | 34,460 | 33,440 |
|
ASTRAZENECA PLC DL-,25 | 886455 | Xetra | 146,250 | 07.08.24 12:31:53 | +1,750 | +1,21% | 146,150 | 146,400 | 145,600 | 144,500 |
